13.03.2014 • News

Credit Suisse to Advise Hanwha on Possible Dow Chlor-alkali Buy

No potential buyers have yet come forward announcing plans to buy the chlor-alkali business Dow Chemical has said it plans to sell. However, South Korea's Hanwha Chemical said it has engaged Credit Suisse to advise it on possible purchases.

A spokesman for Hanwha told the news agency Reuters its interest is "in the early stages."

As part of plans to "right size" its chlorine footprint to meet its needs in downstream markets, Dow in December 2013 said it would carve out "a significant portion" of its chlorine value chain over the next two years.

The U.S. group said it expected to dispose of assets with $5 billion in annual revenue, including more than 40 production units at 11 sites employing nearly 2,000 people.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.